ISIN | LU0446734104 |
---|---|
Valor Number | 10461006 |
Bloomberg Global ID | EUREUA SW |
Fund Name | UBS (Lux) Fund Solutions – UBS Core MSCI Europe UCITS ETF EUR dis |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). |
Peculiarities |
Current Price * | 90.16 EUR | 01.07.2025 |
---|---|---|
Previous Price * | 90.36 EUR | 30.06.2025 |
52 Week High * | 92.59 EUR | 03.03.2025 |
52 Week Low * | 77.56 EUR | 09.04.2025 |
NAV * | 90.16 EUR | 01.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 613,648,058 | |
Unit/Share Assets *** | 474,872,659 | |
Trading Information SIX |
YTD Performance | +8.58% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
---|---|---|
YTD Performance (in CHF) | +7.85% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
1 month | -1.36% |
02.06.2025 - 01.07.2025
02.06.2025 01.07.2025 |
3 months | +1.41% |
01.04.2025 - 01.07.2025
01.04.2025 01.07.2025 |
6 months | +7.90% |
02.01.2025 - 01.07.2025
02.01.2025 01.07.2025 |
1 year | +7.77% |
01.07.2024 - 01.07.2025
01.07.2024 01.07.2025 |
2 years | +23.41% |
03.07.2023 - 01.07.2025
03.07.2023 01.07.2025 |
3 years | +44.06% |
01.07.2022 - 01.07.2025
01.07.2022 01.07.2025 |
5 years | +72.41% |
01.07.2020 - 01.07.2025
01.07.2020 01.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.52% | |
---|---|---|
ASML Holding NV | 2.51% | |
Nestle SA | 2.07% | |
Roche Holding AG | 1.83% | |
Novartis AG Registered Shares | 1.83% | |
Novo Nordisk AS Class B | 1.76% | |
AstraZeneca PLC | 1.73% | |
HSBC Holdings PLC | 1.71% | |
Shell PLC | 1.69% | |
Siemens AG | 1.58% | |
Last data update | 27.06.2025 |
TER | 0.10% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.06% |
Ongoing Charges *** | 0.06% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |